The effectiveness of grass, birch, and mugwort pollen allergen immunotherapy over 18 years: A national cohort study in Denmark

Peter Bager; Gry Poulsen; Jan Wohlfahrt; Mads Melbye

doi:10.1101/2022.11.16.22282380

Article Information

doi

https://doi.org/10.1101/2022.11.16.22282380

History

November 18, 2022.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

Peter Bager1,*,
Gry Poulsen1,2,
Jan Wohlfahrt1 and
Mads Melbye2,3,4,5,6

¹Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
²Aalborg University, Copenhagen, Denmark
³Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
⁴Danish Cancer Society Research Center, Copenhagen, Denmark
⁵Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
⁶K.G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway
⁷Department of Genetics, Stanford University School of Medicine, Stanford, California, USA

↵*Corresponding author:
Peter Bager, Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5/Ørestads Boulevard 5, 2300 Copenhagen S, Denmark. E-mail: pbg{at}ssi.dk.

Author Contributions: Drs Bager and Poulsen had full access to all of the data in the study and together with Dr Wohlfahrt take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: All authors. Acquisition, analysis, and interpretation of data: All authors. Drafting of the manuscript: Drs Bager and Poulsen. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Drs Poulsen and Wohlfahrt. Administrative, technical, or material support: All authors. Study supervision: All authors.